Alphabet Inc’s Tenaya Therapeutics TNYA Stock Holding History

Alphabet Inc’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-915,705	Closed	-$632K	–	29
2026 Q1	$632K	Hold	915,705	–	–	0.02%	26
2025 Q4	$650K	Hold	915,705	–	–	0.03%	26
2025 Q3	$1.48M	Hold	915,705	–	–	0.06%	29
2025 Q2	$559K	Hold	915,705	–	–	0.03%	32
2025 Q1	$522K	Hold	915,705	–	–	0.03%	36
2024 Q4	$1.31M	Hold	915,705	–	–	0.08%	28
2024 Q3	$1.77M	Hold	915,705	–	–	0.1%	27
2024 Q2	$2.84M	Hold	915,705	–	–	0.14%	25
2024 Q1	$4.79M	Hold	915,705	–	–	0.19%	26
2023 Q4	$2.97M	Hold	915,705	–	–	0.14%	28
2023 Q3	$2.34M	Hold	915,705	–	–	0.15%	29
2023 Q2	$5.38M	Hold	915,705	–	–	0.29%	25
2023 Q1	$2.61M	Hold	915,705	–	–	0.14%	30
2022 Q4	$1.84M	Hold	915,705	–	–	0.11%	35
2022 Q3	$2.66M	Hold	915,705	–	–	0.14%	36
2022 Q2	$5.16M	Hold	915,705	–	–	0.28%	33
2022 Q1	$10.8M	Hold	915,705	–	–	0.35%	28
2021 Q4	$17.4M	Hold	915,705	–	–	0.42%	30
2021 Q3	$18.9M	Buy	+915,705	New	+$19.7M	0.45%	23

Other funds holding TNYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alphabet Inc's TNYA Position: Q2 2026 in Review

Alphabet Inc sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 915,705 shares — an estimated $632K sold.

Alphabet Inc first reported a position in TNYA in Q3 2021 and held it in 19 quarters. The position peaked at $18.9M in Q3 2021. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Alphabet Inc reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
Alphabet Inc sold 915,705 Tenaya Therapeutics shares in Q2 2026, an estimated $632K.
Alphabet Inc first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 19 quarters.
Alphabet Inc's Tenaya Therapeutics position peaked at $18.9M in Q3 2021.
101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.